A carregar...
Immune Mechanisms and Pathways Targeted in Type 1 Diabetes
PURPOSE OF REVIEW: The immunosuppressive agent cyclosporine was first reported to lower daily insulin dose and improve glycemic control in patients with new-onset type 1 diabetes (T1D) in 1984. While renal toxicity limited cyclosporine’s extended use, this observation ignited collaborative efforts t...
Na minha lista:
| Publicado no: | Curr Diab Rep |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8053389/ https://ncbi.nlm.nih.gov/pubmed/30168021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11892-018-1066-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|